Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Balchem (BCPC) Other Non-Current Liabilities (2019 - 2022)

Historic Other Non-Current Liabilities for Balchem (BCPC) over the last 4 years, with Q4 2022 value amounting to $26.8 million.

  • Balchem's Other Non-Current Liabilities rose 9555.13% to $26.8 million in Q4 2022 from the same period last year, while for Dec 2022 it was $26.8 million, marking a year-over-year increase of 9555.13%. This contributed to the annual value of $26.8 million for FY2022, which is 9555.13% up from last year.
  • Latest data reveals that Balchem reported Other Non-Current Liabilities of $26.8 million as of Q4 2022, which was up 9555.13% from $30.5 million recorded in Q3 2022.
  • Balchem's Other Non-Current Liabilities' 5-year high stood at $30.5 million during Q3 2022, with a 5-year trough of $443000.0 in Q1 2020.
  • In the last 4 years, Balchem's Other Non-Current Liabilities had a median value of $6.9 million in 2020 and averaged $10.4 million.
  • Its Other Non-Current Liabilities has fluctuated over the past 5 years, first crashed by 5304.31% in 2020, then surged by 142550.79% in 2021.
  • Balchem's Other Non-Current Liabilities (Quarter) stood at $2.1 million in 2019, then soared by 454.35% to $11.7 million in 2020, then rose by 17.62% to $13.7 million in 2021, then skyrocketed by 95.55% to $26.8 million in 2022.
  • Its last three reported values are $26.8 million in Q4 2022, $30.5 million for Q3 2022, and $24.8 million during Q2 2022.